XML 61 R44.htm IDEA: XBRL DOCUMENT v3.25.3
EQUITY METHOD INVESTMENT AND NOTE RECEIVABLE (Tables)
12 Months Ended
Sep. 30, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Financial Information
Summarized financial information for Copeland for 2024 and 2023 is presented below. Copeland's results only reflect activity subsequent to the Company's divestiture of its majority stake and through the completion of the sale of the 40 percent non-controlling common equity interest.

 2023 2024 
Net sales $1,677 $4,323 
Gross profit$479 $1,495 
Income (loss) from continuing operations$(442)$(326)
Net income (loss)$(442)$(326)
Net income (loss) attributable to shareholders$(442)$(322)